Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Oct 24 - Oct 29
Cesta, M
There may also be insurance coverage issues with changing medications
Lilly releases Zepbound (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Distributed through LillyDirect 's self-pay channel, Zepbound single-dose vials are at least 50% less than the list price of all other incretin medicines for obesity (tirzepatide) 2.5 mg and 5 mg single-dose vials are available for self-pay for patients with an on-label prescription, significantly expanding the supply of Zepbound in response to high demand
The region benefits from advanced diagnostic capabilities, strong clinical awareness among healthcare providers, and robust reimbursement systems, which contribute to a higher uptake of GLP-1 therapies
This appetite suppression aids in controlling calorie intake, making it easier for patients to stick to a healthy eating plan
US$ 27.33
US$ 21.55
US$ 22.03
US$ 29.60
